COA Requirements for 3-Chlorobenzyl Cyanide Bulk Procurement
- Key COA parameters must include assay purity, residual solvents, heavy metals, and water content to meet pharmaceutical intermediate standards.
- Global bulk buyers require full regulatory documentation—COA, SDS, and transport compliance—for seamless customs clearance and GMP alignment.
- Industrial purity validation through HPLC/GC methods is critical when sourcing 3-Chlorobenzyl cyanide for lorazepam or other API syntheses.
When procuring 3-Chlorobenzyl cyanide (CAS: 1529-41-5) in bulk for pharmaceutical applications, the Certificate of Analysis (COA) is not merely a quality document—it is a foundational compliance instrument. As a key pharmaceutical intermediate used in the synthesis of anxiolytics like lorazepam, this compound demands rigorous analytical validation. Buyers must ensure that every COA meets international pharmacopeial expectations (e.g., USP, EP) while reflecting the actual industrial purity of the batch supplied.
Essential Certificate of Analysis (COA) Parameters for CAS 1529-41-5
A compliant COA for 3-Chlorobenzyl cyanide—also known as (3-Chlorophenyl)acetonitrile or m-Chlorobenzyl cyanide—must contain quantifiable data across several critical quality attributes. These are non-negotiable for GMP-aligned supply chains:
- Assay Purity (HPLC/GC): Typically ≥98.0% for pharmaceutical use; some high-end syntheses demand ≥99.0%.
- Residual Solvents: Must comply with ICH Q3C guidelines (e.g., toluene, DMF, or dichloromethane below permissible limits).
- Water Content (KF): Usually ≤0.5% to prevent hydrolysis of the nitrile group during storage or reaction.
- Heavy Metals: Total heavy metals (as Pb) should be ≤10 ppm per USP <231>.
- Related Substances/Impurities: Identification and quantification of process-related impurities such as unreacted 3-chlorobenzaldehyde or dimeric byproducts.
- Appearance & Physical State: Clear to pale yellow liquid, free from particulates.
These specifications directly impact the efficiency of downstream chemical synthesis. For instance, elevated moisture or solvent residues can reduce yield in the Strecker or cyanation steps common in benzodiazepine manufacturing.
Regulatory Documentation Needed for International Bulk Shipments
Beyond the COA, global procurement of 3-Chlorophenylacetonitrile requires a suite of regulatory documents to satisfy customs, environmental, and safety authorities:
| Document | Purpose | Key Details |
|---|---|---|
| Certificate of Analysis (COA) | Batch-specific quality verification | Includes lot number, test methods (e.g., GC-FID, HPLC-UV), acceptance criteria, and signature of QA officer |
| Safety Data Sheet (SDS) | Hazard communication & handling | GHS-compliant; includes toxicity (oral LD50 ~200 mg/kg in rats), flammability, and first-aid measures |
| Non-Hazardous Declaration / Transport Docs | Shipping compliance | Despite being classified as "Air Excepted," proper UN packaging group and temperature controls (+4°C storage, RT shipping) must be documented |
| REACH / TSCA Compliance Statement | Regional chemical regulation | Confirms registration status in EU, USA, and other major markets |
NINGBO INNO PHARMCHEM CO.,LTD. provides fully traceable, digitally signed COAs with every bulk shipment, ensuring transparency from raw material sourcing through final QC release. Our documentation supports seamless import into regulated markets including the EU, North America, and ASEAN regions.
Validating Supplier COAs Against Pharmacopeial Standards
Not all COAs are created equal. A technically sound COA must align with recognized compendial monographs—even if 3-Chlorobenzyl cyanide itself lacks a direct USP entry, its use as a pharmaceutical intermediate subjects it to general chapters like USP <467> (residual solvents) and <232>/<233> (elemental impurities).
Buyers should verify:
- Whether analytical methods are validated per ICH Q2(R1).
- If impurity thresholds reflect the intended synthesis route (e.g., aldehyde-based vs. halogen displacement routes may generate different byproducts).
- That the COA includes the molecular formula (C8H6ClN), molecular weight (151.59), and CAS number (1529-41-5) without discrepancy.
At NINGBO INNO PHARMCHEM CO.,LTD., our QC lab employs orthogonal methods—GC-MS for volatile impurities, HPLC-PDA for assay, and ICP-MS for elemental screening—to guarantee data integrity. This rigor ensures consistent bulk price competitiveness without compromising on compliance or performance in API manufacturing.
For clients scaling up production of CNS-active APIs, reliable access to high-purity 3-Chlorobenzyl cyanide is mission-critical. By insisting on comprehensive COA documentation and partnering with a vertically integrated global manufacturer, pharmaceutical developers mitigate supply chain risk while maintaining synthesis reproducibility.